On Sep 20, 2021 Pegasus Biotech closed a Grant round and raised CA$100,000 from investors, featuring lead investors . About the company: Pegasus Biotech is […]
Grant – Rhaeos
On Sep 16, 2021 Rhaeos closed a Grant round and raised $4,000,000 from National Institute of Neurological Disorders and Stroke, featuring lead investors National Institute […]
Series B – Amolyt Pharma
On Sep 16, 2021 Amolyt Pharma closed a Series B round and raised $80,000,000 from Andera Partners, ATEM Capital, Bpifrance, Credit Agricole Entreprises, Eurazeo, Kurma […]
Series B – Othram
On Sep 16, 2021 Othram closed a Series B round and raised $18,000,000 from Gigafund, featuring lead investors Gigafund. About the company: Othram is located […]
Series C – IASO Biotherapeutics
On Sep 16, 2021 IASO Biotherapeutics closed a Series C round and raised $108,000,000 from CCB International, CDH Investments, CNCB Capital, Co-Stone Venture Capital, Everbright, […]
Series B – 54gene
On Sep 16, 2021 54gene closed a Series B round and raised $25,000,000 from Adjuvant Capital, Cathay Innovation, Endeavor Catalyst, Ingressive Capital, KdT Ventures, Plexo […]
Series A – Epicura
On Sep 16, 2021 Epicura closed a Series A round and raised €5,000,000 from Europ Assistance, featuring lead investors Europ Assistance. About the company: Epicura […]
Seed Round – HeartLab
On Sep 16, 2021 HeartLab closed a Seed round and raised NZ$3,500,000 from Dylan Field, Founders Fund, Icehouse Ventures, Outset Ventures, featuring lead investors Founders […]
Grant – Rhaeos
On Sep 16, 2021 Rhaeos closed a Grant round and raised $4,000,000 from National Institute of Neurological Disorders and Stroke, featuring lead investors National Institute […]
Series B – Amolyt Pharma
On Sep 16, 2021 Amolyt Pharma closed a Series B round and raised $80,000,000 from Andera Partners, ATEM Capital, Bpifrance, Credit Agricole Entreprises, Eurazeo, Kurma […]
